Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial)

BACKGROUND AND PURPOSE: Screening for and treatment of latent tuberculosis (TB) in patients with end-stage kidney disease (ESKD) are recommended. However, there is limited evidence on safety and treatment completion in this population. The objective of the study is to evaluate three short-course rif...

Descripción completa

Detalles Bibliográficos
Autores principales: Santin, Miguel, Perez-Recio, Sandra, Grijota, Maria D., Anibarro, Luis, Barcala, Jose M., De Souza-Galvao, Maria L., Gijon, Paloma, Luque, Rafael, Sanchez, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586383/
https://www.ncbi.nlm.nih.gov/pubmed/36269714
http://dx.doi.org/10.1371/journal.pone.0276387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586383/
https://www.ncbi.nlm.nih.gov/pubmed/36269714
http://dx.doi.org/10.1371/journal.pone.0276387

Ejemplares similares